Nigel O'Neil

Happy to see the latest collaboration between the @HieterLab and @StirlingLab published in DNA Repair sciencedirect.com/science/articl…

In a bizarre day in which we learned that there actually is no Epstein client list after being promised its release, Trump one-upped his hapless administration and announced that he was turning his back on one of the most important planks in his platform: Ukraine. With Netanyahu at his side, he announced that he would be sending weapons to Ukraine after all and that he is ending sanctions on al-Qaeda-ruled Syria at the request of the Israeli prime minister. Also today, the US to spend $1.5 billion building military bases...in Israel! Watch @RonPaul & @DanielLMcAdams below:

Excited to see our collaboration with the Stirling Lab published at PNAS. Great job by Anthony Oppedisano and co-authors. @ubcmsl pnas.org/doi/10.1073/pn…

Our collaboration with @StirlingLab now out at PNAS. Deep structure–function analysis of the endonuclease Mus81 with dominant mutational scanning | PNAS pnas.org/doi/10.1073/pn…

Excited to see this interesting story get published. @ubcmsl Distribution of haploid chromosomes into separate nuclei in two pathogenic fungi | Science science.org/doi/10.1126/sc…

Arrowsmith Genetics is excited to be in Round 3 of the New Ventures BC competition. Looking forward to meeting our mentors and other NVBC ventures. #NVBC2023 #BCtech #BCentrepreneurs

#sweetbiopharmaday #ArrowsmithGenetics

@LumiraVentures @ubcentrepreneur Dr. Peter Stirling of @ArrowsmithGx presented their AGx Mutational Target Mapping (MTM) platform, which optimizes drug targeting strategies, leading to new therapeutic candidates.

Invest in BC presented by @LumiraVentures kicks off on November 2nd! At 12:45 pm PT, the third session will commence, and attendees will hear company pitches from the third group of therapeutics companies. More information and registration: lnkd.in/geQTDp4f

@ThatEricAlper Marie - Townes Van Zandt

Invest in BC presented by @LumiraVentures is happening on November 2nd and 3rd! Check out the first group of companies that are presenting from the Therapeutics sector. Info and registry: lifesciencesbc.ca/event/invest-i… @ArrowsmithGx @clairvoyantrx @IntegratedNTX @MesintelTX

Discover what life sciences companies in BC have to offer as they showcase and pitch their innovations to a range of high-profile stakeholders and investors at our 7th annual Invest in BC presented by @LumiraVentures on November 2nd-3rd. RSVP: lifesciencesbc.ca/event/invest-i… #LSBCInvest

🎉 Congratulations to everyone who received awards in August! ☀️ Dr. Philip Hieter (@HieterLab) received a @CIHR_IRSC grant to expand the impact and reach of the Canadian ‘#RareDiseases: Models and Mechanisms’ Network. See more award winners: scienceinvancouver.com/2022/09/01/aug…

The Hieter Lab is at #yeast22. Anthony Oppedisano is presenting "Mutational Scanning to find Synthetic Lethal interactions with the repair endonuclease Mus81" on Friday evening. Poster 177B.

.@SBME_UBC and @Amgen announced the inaugural 2022 Amgen Golden Ticket 🎟️ at SBME Innovates, providing a launchpad for two promising UBC #SpinOff ventures, Arrowsmith Genetics and SeraGene. Learn more about the program: bit.ly/3tz6P04

NDP Expands Private Long-Term Care | The Tyee Competitive tendering is designed to 1) help for-profit corporations win Govt contracts and 2) help political parties ditch their campaign commitments. ⁦@BCHC⁩ ⁦@DrNancyOlivieri⁩ ⁦@DrVivianS⁩ thetyee.ca/News/2022/05/0…

@j_mcelroy Slow - Have Not been the Same. Expo86 legends. youtu.be/dD0xeHKAPOA

alright justin, you got this, just have to make this a bracket now

RT this and a buck will be donated to #KickChildhoodCancer 💛 #VWFC #VANvDAL

@HieterLab uses CRISPR-Cas9 screening to explore the context-dependency of genetic interactions of the cancer-mutated cohesin gene STAG2 in three different cellular backgrounds @HieterLab @ubcmsl life-science-alliance.org/content/4/11/e…